CytomX Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2016 | — | -396.1% | -391.5% |
| FY2017 | — | -64.6% | -60.2% |
| FY2018 | — | -130.9% | -142.2% |
| FY2019 | — | -525.9% | -493.7% |
| FY2020 | — | -117.7% | -94.7% |
| FY2021 | — | -311.0% | -310.5% |
| FY2022 | — | -190.6% | -186.8% |
| FY2023 | — | -6.4% | -0.6% |
| FY2024 | — | 18.1% | 23.1% |
| FY2025 | — | -29.3% | -22.8% |